Telomir Pharmaceuticals Inc.

06/15/2026 | Press release | Distributed by Public on 06/15/2026 06:00

Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Telomir Pharmaceuticals Inc. published this content on June 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 15, 2026 at 12:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]